NCT06383546

Brief Summary

Congenital heart disease (CHD) is the most common congenital disease in children. The early detection, diagnosis and treatment of CHD in children is of great significance to improve the prognosis and reduce the mortality of children, but the current screening methods have limitations. Electrocardiogram (ECG), as an economical and rapid means of heart disease detection, has a very important value in the auxiliary diagnosis of CHD.Big data and deep learning technologies in artificial intelligence (AI) have shown great potential in the medical field. The advent of the big data era provides rich data resources for the in-depth study of CHD ECG signals in children. The development of deep learning technology, especially the breakthrough in the field of image recognition, provides a strong technical support for the intelligent analysis of electrocardiogram. The particularity of children electrocardiogram requires the development of a special algorithm model. At present, the research on the application of deep learning models to identify children's electrocardiograms is limited, and the training and verification from large data sets are lacking. Based on the Chinese Congenital Heart Disease Collaborative Research Network, this project aims to integrate data and deep learning technology to develop a set of intelligent electrocardiogram assisted diagnosis system (CHD-ECG AI system) suitable for children with CHD, so as to improve the early detection rate of CHD and improve the efficiency of congenital heart disease screening.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

12 months

First QC Date

April 22, 2024

Last Update Submit

April 22, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Large-scale ECG database for children

    The ECG data of children from multiple centers were collected and collated, including common and rare CHD types and normal children's ECG, to construct a large-scale ECG database covering different ages and CHD diseases. In addition, the original ECG data (digital signals or ECG images) will be pre-processed to make it conform to the input standards of deep learning models, so as to improve the quality and efficiency of subsequent model training and reduce the heterogeneity of multi-center ECG data.

    2024.01.01-2024.12.30

  • Artificial intelligence-assisted electrocardiogram model for CHD in Children

    The deep neural network model will be established based on algorithms such as convolutional neural network, transformers and Autoencoders, and will be trained and verified in the multi-center children's ECG dataset (85%) established based on CCHDnet, so as to continuously optimize the model and improve the diagnostic performance of the model. Further, the deep learning model based on the single disease of CHD will be integrated, and the CHD-ECG AI system will be built, and the model will eventually automatically extract and recognize the general basic information such as the age and gender of the child through the ECG, and then predict and classify the potential CHD characteristics in the ECG based on this. The research group initially selected the representative subtypes of CHD - atrial septal defect and pulmonary hypertension as the initial direction of exploration.

    2024.01.01-2025.12.30

Study Arms (3)

Atrial septal defect

Pulmonary hypertension

Control

Eligibility Criteria

Age3 Months - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Our dataset consisted of retrospective data from patients aged under 18 years who had complete ECG, echocardiography, examination and medical history information.

You may qualify if:

  • The age of first visit was from 3 months after birth to 18 years old;
  • In the atrial septal defect group, patients in the case group were required to complete ECG examination and confirmed by careful cardiac ultrasonography that there was a simple secondary atrial septal defect without other complex heart malformations (such as ectopic pulmonary vein drainage, trunk conus artery malformation, interrupted aortic arch, primary pulmonary hypertension, etc.). In the pulmonary hypertension group, the presence of CHD associated pulmonary hypertension was confirmed by careful cardiac ultrasonography examination. The control group was the patients with normal intracardiac structure examined by cardiac ultrasonography. The time interval between ECG examination and echocardiography examination of all patients was \< 1 month;
  • No major illness at the time of initial visit (non-life-threatening organic disease caused by congenital heart disease).

You may not qualify if:

  • Age of first visit \< 3 months or \> 18 years old;
  • Complicated congenital heart disease (such as anomalous pulmonary venous drainage, trunk conus artery malformation, interrupted aortic arch, primary pulmonary hypertension, etc.);
  • The clinical information is incomplete, including the lack of ECG or echocardiography information, or the time interval between ECG and echocardiography is \> 1 month;
  • Life-threatening diseases associated with other organ systems;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

RECRUITING

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Chief Pediatrician

Study Record Dates

First Submitted

April 22, 2024

First Posted

April 25, 2024

Study Start

January 1, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2025

Last Updated

April 25, 2024

Record last verified: 2024-04

Locations